Antidiabetic action of nateglinide includes augmentation of glucagon-like peptide-1 activity mediated partly through inhibition of DPP IV mediated degradation

Aine McKillop; NA Duffy; BD Green; Nigel Irwin; Victor Gault; Finbarr O'Harte; Peter Flatt

Antidiabetic action of nateglinide includes augmentation of glucagon-like peptide-1 activity mediated partly through inhibition of DPP IV mediated degradation

Aine McKillop, NA Duffy, BD Green, Nigel Irwin, Victor Gault, Finbarr O'Harte, Peter Flatt

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	0882
Journal	Diabetologia
Volume	50
Issue number	Suppl.
Publication status	Published - Sep 2007

Bibliographical note

43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam, NETHERLANDS,
SEP 18-21, 2007

Cite this

@article{d5ad1669684144a8ba8e9f984b349d8e,

title = "Antidiabetic action of nateglinide includes augmentation of glucagon-like peptide-1 activity mediated partly through inhibition of DPP IV mediated degradation",

author = "Aine McKillop and NA Duffy and BD Green and Nigel Irwin and Victor Gault and Finbarr O'Harte and Peter Flatt",

note = "43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam, NETHERLANDS, SEP 18-21, 2007",

year = "2007",

month = sep,

language = "English",

volume = "50",

pages = "0882",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "Suppl.",

}

TY - JOUR

T1 - Antidiabetic action of nateglinide includes augmentation of glucagon-like peptide-1 activity mediated partly through inhibition of DPP IV mediated degradation

AU - McKillop, Aine

AU - Duffy, NA

AU - Green, BD

AU - Irwin, Nigel

AU - Gault, Victor

AU - O'Harte, Finbarr

AU - Flatt, Peter

N1 - 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Amsterdam, NETHERLANDS, SEP 18-21, 2007

PY - 2007/9

Y1 - 2007/9

M3 - Article

VL - 50

SP - 0882

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - Suppl.

ER -